Cargando…

Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors

PURPOSE: To examine whether sociodemographic characteristics, access to care, risk behavior factors, and chronic health conditions were associated with colorectal cancer (CRC) screening utilization among breast, cervical, prostate, skin, and lung cancer survivors. METHODS: We analyzed the 2020 Behav...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Meng-Han, Moore, Justin X., Odhiambo, Lorriane A., Andrzejak, Sydney E., Tingen, Martha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549837/
https://www.ncbi.nlm.nih.gov/pubmed/36217067
http://dx.doi.org/10.1007/s11764-022-01258-0
_version_ 1784805760776011776
author Tsai, Meng-Han
Moore, Justin X.
Odhiambo, Lorriane A.
Andrzejak, Sydney E.
Tingen, Martha S.
author_facet Tsai, Meng-Han
Moore, Justin X.
Odhiambo, Lorriane A.
Andrzejak, Sydney E.
Tingen, Martha S.
author_sort Tsai, Meng-Han
collection PubMed
description PURPOSE: To examine whether sociodemographic characteristics, access to care, risk behavior factors, and chronic health conditions were associated with colorectal cancer (CRC) screening utilization among breast, cervical, prostate, skin, and lung cancer survivors. METHODS: We analyzed the 2020 Behavioral Risk Factor Surveillance System (BRFSS) data on 9780 eligible cancer survivors. Descriptive statistics and multivariable logistic regression models were applied to assess the association between guideline-concordant CRC screening and the mentioned characteristics. RESULTS: Overall, 81.9%, 65%, 88%,78.1%, and 80.1% of breast, cervical, prostate, skin, and lung cancer survivors received CRC screening, respectively (p-value < 0.001). In multivariable analysis, breast, cervical, and skin cancer survivors aged 60 years or older were associated with higher odds of receiving CRC screening. Respondents that had their recency of routine checkup two or more years before had lower odds of having CRC screening among cervical (OR = 0.06; 95% CI, 0.02–0.22), prostate (OR = 0.26; 95% CI, 0.14–0.49), and skin cancer (OR = 0.50; 95% CI, 0.36–0.70) survivors. The presence of chronic diseases was also associated with guideline-concordant CRC screening among breast, prostate, and skin cancer survivors. CONCLUSIONS: Our findings provide important evidence on potential factors that are associated with guideline-concordant CRC screening utilization across different cancer survivors, which include older age, recency of routine checkup, and multiple chronic diseases. Moreover, variation in CRC screening utilization across cancer survivors may highlight missed opportunities for secondary cancer prevention. IMPLICATIONS FOR CANCER SURVIVORS: Establishing clear CRC screening guidelines and including patient-provider communication on recommendation in cancer survivorship care may increase adherence to CRC screening. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-022-01258-0.
format Online
Article
Text
id pubmed-9549837
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-95498372022-10-11 Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors Tsai, Meng-Han Moore, Justin X. Odhiambo, Lorriane A. Andrzejak, Sydney E. Tingen, Martha S. J Cancer Surviv Article PURPOSE: To examine whether sociodemographic characteristics, access to care, risk behavior factors, and chronic health conditions were associated with colorectal cancer (CRC) screening utilization among breast, cervical, prostate, skin, and lung cancer survivors. METHODS: We analyzed the 2020 Behavioral Risk Factor Surveillance System (BRFSS) data on 9780 eligible cancer survivors. Descriptive statistics and multivariable logistic regression models were applied to assess the association between guideline-concordant CRC screening and the mentioned characteristics. RESULTS: Overall, 81.9%, 65%, 88%,78.1%, and 80.1% of breast, cervical, prostate, skin, and lung cancer survivors received CRC screening, respectively (p-value < 0.001). In multivariable analysis, breast, cervical, and skin cancer survivors aged 60 years or older were associated with higher odds of receiving CRC screening. Respondents that had their recency of routine checkup two or more years before had lower odds of having CRC screening among cervical (OR = 0.06; 95% CI, 0.02–0.22), prostate (OR = 0.26; 95% CI, 0.14–0.49), and skin cancer (OR = 0.50; 95% CI, 0.36–0.70) survivors. The presence of chronic diseases was also associated with guideline-concordant CRC screening among breast, prostate, and skin cancer survivors. CONCLUSIONS: Our findings provide important evidence on potential factors that are associated with guideline-concordant CRC screening utilization across different cancer survivors, which include older age, recency of routine checkup, and multiple chronic diseases. Moreover, variation in CRC screening utilization across cancer survivors may highlight missed opportunities for secondary cancer prevention. IMPLICATIONS FOR CANCER SURVIVORS: Establishing clear CRC screening guidelines and including patient-provider communication on recommendation in cancer survivorship care may increase adherence to CRC screening. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-022-01258-0. Springer US 2022-10-10 /pmc/articles/PMC9549837/ /pubmed/36217067 http://dx.doi.org/10.1007/s11764-022-01258-0 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Tsai, Meng-Han
Moore, Justin X.
Odhiambo, Lorriane A.
Andrzejak, Sydney E.
Tingen, Martha S.
Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
title Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
title_full Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
title_fullStr Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
title_full_unstemmed Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
title_short Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
title_sort colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549837/
https://www.ncbi.nlm.nih.gov/pubmed/36217067
http://dx.doi.org/10.1007/s11764-022-01258-0
work_keys_str_mv AT tsaimenghan colorectalcancerscreeningutilizationamongbreastcervicalprostateskinandlungcancersurvivors
AT moorejustinx colorectalcancerscreeningutilizationamongbreastcervicalprostateskinandlungcancersurvivors
AT odhiambolorrianea colorectalcancerscreeningutilizationamongbreastcervicalprostateskinandlungcancersurvivors
AT andrzejaksydneye colorectalcancerscreeningutilizationamongbreastcervicalprostateskinandlungcancersurvivors
AT tingenmarthas colorectalcancerscreeningutilizationamongbreastcervicalprostateskinandlungcancersurvivors